SEMNUR PHARMACEUTICALS Trademark

Trademark Overview

On Monday, July 8, 2019, a trademark application was filed for SEMNUR PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SEMNUR PHARMACEUTICALS trademark a serial number of 88503719. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2023. This trademark is owned by Semnur Pharmaceuticals, Inc.. The SEMNUR PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, including lumbosacral radicular pain and sciatica; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical use
semnur pharmaceuticals

General Information

Serial Number88503719
Word MarkSEMNUR PHARMACEUTICALS
Filing DateMonday, July 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements

Goods and ServicesPain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, including lumbosacral radicular pain and sciatica; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical use
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSemnur Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameSemnur Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 24, 2022SOU EXTENSION 5 GRANTED
Friday, May 20, 2022SOU EXTENSION 5 FILED
Tuesday, May 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 17, 2021SOU EXTENSION 4 GRANTED
Friday, December 17, 2021SOU EXTENSION 4 FILED
Friday, December 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 18, 2021SOU EXTENSION 3 GRANTED
Friday, June 18, 2021SOU EXTENSION 3 FILED
Friday, June 18, 2021SOU TEAS EXTENSION RECEIVED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 16, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 16, 2020SOU EXTENSION 2 FILED
Wednesday, December 16, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2020SOU EXTENSION 1 GRANTED
Monday, July 13, 2020SOU EXTENSION 1 FILED
Monday, July 13, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2019ASSIGNED TO LIE
Monday, October 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 26, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, September 26, 2019PRIORITY ACTION E-MAILED
Thursday, September 26, 2019PRIORITY ACTION WRITTEN
Tuesday, September 24, 2019ASSIGNED TO EXAMINER
Tuesday, July 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 11, 2019NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals semnur pain treatment dexamethasone sodium medical phosphate relief radicular sciatica lumbosacral